Back

Complexities of patient care in ATTR amyloidosis

30 August 2026 (15:20 - 15:30)
Organised by: Logo
Congress Presentation Part of: Targeting the source: in vivo CRISPR-based gene editing for transthyretin amyloid cardiomyopathy (ATTR-CM) Treatment Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Joban Vaishnav

The Johns Hopkins University School of Medicine, Baltimore (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor A. Masri (Portland, US)
Presentation thumbnail
The utility of CRISPR gene editing in cardiology
Professor R. Witteles (Stanford, US)
Presentation thumbnail
Exploring CRISPR-based gene editing in ATTR-CM
Doctor A. Masri (Portland, US)
Presentation thumbnail
Targeting the source: in vivo CRISPR-based gene editing for ATTR-CM - Q&A from the audience

Access the full session

Session thumbnail
Targeting the source: in vivo CRISPR-based gene editing for transthyretin amyloid cardiomyopathy (ATTR-CM)
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 15:20 CET
You may be interested in
thumbnail
Congress Session
When to look for amyloidosis
18 May 2025
thumbnail
Congress Presentation
Recommendations for the holistic care of patients with hereditary ATTR amyloidosis: an international Delphi consensus of patient advocates and multidisciplinary healthcare professionals
23 June 2023
thumbnail
Congress Presentation
RNA-based therapy in amyloidosis
27 August 2023
thumbnail
Congress Presentation
Amyloid progression or comorbidities? Differentiating management for optimal outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources